Physician
Consultative Genomics, PLLC
Consultative Genomics, PLLC was paid $184K by Medicaid between Sep 2018 and Apr 2024, across 46 billing codes. Its largest line is 81479, Unlisted molecular pathology procedure — 36% of everything it billed.
33Billing provider infoCONSULTATIVE GENOMICS, PLLC
BELLAIRE, TX 77401
BELLAIRE, TX 77401
33aNPI1417391533assigned 04/19/2013
33bProvider typeAnatomic Pathology Physician
28Total paid$184K
24GClaims8,399
24DCodes billed46
24AFirst – last monthSep 2018 – Apr 2024
Compared with peers
Next to other Anatomic Pathology Physician providers in Texas
Rank by total paid#3 of 10
Median peer was paid$13K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 226 | $66K | |
| 2019 | 1,873 | $72K | |
| 2020 | 332 | $10K | |
| 2021 | 587 | $757.50 | |
| 2022 | 4,833 | $31K | |
| 2024incomplete | 548 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81479 | Unlisted molecular pathology procedure | 36% | 500 | 80 | $66K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 23% | 122 | 110 | $43K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.9% | 1,499 | 575 | $18K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5.7% | 595 | 392 | $11K |
| 87486 | 4.0% | 484 | 363 | $7K | |
| 87640 | 3.7% | 501 | 379 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.5% | 1,688 | 705 | $6K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.1% | 477 | 261 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.9% | 286 | 221 | $5K |
| 81292 | 1.2% | 12 | 12 | $2K | |
| 81298 | 1.1% | 12 | 12 | $2K | |
| G0452 | Molecular pathology procedure; physician interpretation and report | 1.1% | 207 | 170 | $2K |
34 more codes
| 80505 | <1% | 149 | $2K | |
| 81295 | <1% | 12 | $1K | |
| 81404 | <1% | 21 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 43 | $757.50 |
| 80506 | <1% | 149 | $733.17 | |
| 99451 | <1% | 120 | $700.68 | |
| 81226 | <1% | 30 | $360.73 | |
| 87150 | <1% | 48 | $350.88 | |
| 81225 | <1% | 31 | $233.09 | |
| 81350 | <1% | 30 | $187.20 | |
| 81328 | <1% | 30 | $139.85 | |
| 81335 | <1% | 30 | $139.85 | |
| 81247 | <1% | 17 | $139.85 | |
| 81232 | <1% | 31 | $139.85 | |
| 81230 | <1% | 31 | $139.85 | |
| 81227 | <1% | 30 | $139.85 | |
| 81231 | <1% | 31 | $139.85 | |
| 81401 | <1% | 19 | $109.60 | |
| 87581 | <1% | 220 | $87.73 | |
| 87541 | <1% | 233 | $87.73 | |
| 81355 | <1% | 30 | $70.56 | |
| 81241 | <1% | 30 | $58.70 | |
| 81240 | <1% | 30 | $52.55 | |
| 81291 | <1% | 30 | $52.27 | |
| 87481 | 0% | 19 | $0.00 | |
| 87653 | 0% | 19 | $0.00 | |
| 87631 | 0% | 234 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 201 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 21 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 24 | $0.00 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 14 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 21 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 17 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSENBLATT, KEVIN (OWNER)